Theranos.World
The post examines the rise and fall of Theranos, the blood‑testing company that promised revolutionary technology but faced regulatory scrutiny and legal challenges. It highlights the company’s claims, the subsequent investigations, and the impact on the biotech industry. The discussion also touches on the role of venture capital, the influence of high‑profile investors, and the broader implications for startup governance.